Fractional Leadership Services

Experienced CIO & CISO Leadership for Biotechs
Celito plugs seasoned IT executives into your C‑suite, giving you Fortune 500 discipline without the full‑time payroll burden. We architect an inspection and scale ready digital backbone that keeps regulators satisfied, investors confident, and scientists innovating.
Life Sciences companies hit a wall when DIY IT can’t keep pace with clinical milestones, finance audits, or IPO ambitions. Celito’s 125+ experts support 75+ biotech clients worldwide, guiding them from Seed to Commercialization with 24 × 7 global coverage.

Why Celito?

Compliance first DNA

21 CFR Part 11, GxP, GDPR, HIPAA baked into every decision.

Helyx™ Product Suite

Celito engineered, Azure‑native modules for quality, clinical, regulatory, and data management.

Integrated vCIO + vCISO Model

Security, infrastructure, and business enablement steered from one playbook.

Roadmaps that Stick

Boots‑on‑the‑ground program managers, not slideware.

What We Deliver

Fractional Leadership Services

Fractional Leadership Services - OnDemand CIO, CISO, PMO, and domain‑specific leads who deliver strategic oversight without full‑time overhead.

Cyber Governance & vCISO

IT Steering & Audit Committee

M&A / IPO Readiness

Our 4‑Step Methodology

Assess

Rapid diagnostics across people, process, tech, and risk.

Architect

Target operating model & roadmap mapped to value inflection points.

Execute

Project execution with gated milestones and real‑time KPI tracking.

Advance

Continuous improvement sprints & quarterly strategy refresh.

Flexible Ways to Engage

Model
Typical Use Case
Commitment
Fractional Leadership Retainer
Ongoing C‑suite coverage for Series A+ biotechs
1–2 days / week
Interim CIO/CISO
Bridge executive gap during search or turnaround
3–6 months
Program‑Based Advisory
Focused initiative (e.g., SOX readiness, NIST uplift)
Project‑based
Board / Audit Committee Advisor
Independent oversight & reporting
Quarterly

Proven Outcomes

Full SEC & SOX compliance achieved ahead of IPO for mid‑stage biotech clients.

Over 50 % reduction in projected data breach risk after implementing 24 × 7 monitoring and encryption.

More than 30 % reduction in total IT operating costs through Celito’s fractional leadership and integrated roadmap delivery.

Clients close GxP audits with fewer than five minor observations on average.